CINV Treatment Market: Is "Medical Cannabis" Becoming a Mainstream Antiemetic in 2026? A defining 2026 industry trend is the rapid legitimization and growth of the "Cannabinoid" segment within the CINV treatment space. In 2026, cannabinoids are recognized as the fastest-growing drug class in the market, as more clinicians prescribe them for "refractory CINV"—cases where traditional medications have failed. This 2026 shift is supported by evolving legal landscapes and new...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
